JGA Issues Written Reprimand to Sawai over GMP Issues

January 30, 2024
The Japan Generic Medicines Association (JGA) has issued a written reprimand to Sawai Pharmaceutical after the generic giant was slapped with business improvement orders over its fraudulent testing of the gastritis and gastric ulcer drug Teprenone Capsules. A reprimand is...read more